AU2001276831A1 - Delivery vehicle composition and methods for delivering antigens and other drugs - Google Patents

Delivery vehicle composition and methods for delivering antigens and other drugs

Info

Publication number
AU2001276831A1
AU2001276831A1 AU2001276831A AU7683101A AU2001276831A1 AU 2001276831 A1 AU2001276831 A1 AU 2001276831A1 AU 2001276831 A AU2001276831 A AU 2001276831A AU 7683101 A AU7683101 A AU 7683101A AU 2001276831 A1 AU2001276831 A1 AU 2001276831A1
Authority
AU
Australia
Prior art keywords
drugs
methods
delivery vehicle
vehicle composition
delivering antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276831A
Other languages
English (en)
Inventor
Joan P. Blonder
Claire M. Coeshott
Timothy C Rodell
Gary J Rosenthal
Wren H. Schauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RxKinetix Inc
Original Assignee
RxKinetix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RxKinetix Inc filed Critical RxKinetix Inc
Publication of AU2001276831A1 publication Critical patent/AU2001276831A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU2001276831A 2000-06-22 2001-06-22 Delivery vehicle composition and methods for delivering antigens and other drugs Abandoned AU2001276831A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US60265400A 2000-06-22 2000-06-22
US09602654 2000-06-22
US27826701P 2001-03-23 2001-03-23
US60278267 2001-03-23
PCT/US2001/020096 WO2001098206A1 (en) 2000-06-22 2001-06-22 Delivery vehicle composition and methods for delivering antigens and other drugs

Publications (1)

Publication Number Publication Date
AU2001276831A1 true AU2001276831A1 (en) 2002-01-02

Family

ID=26959007

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276831A Abandoned AU2001276831A1 (en) 2000-06-22 2001-06-22 Delivery vehicle composition and methods for delivering antigens and other drugs

Country Status (4)

Country Link
US (1) US7767197B2 (de)
EP (1) EP1315672A4 (de)
AU (1) AU2001276831A1 (de)
WO (1) WO2001098206A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371994C (en) * 1999-02-26 2010-09-28 Guido Grandi Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
US6645947B1 (en) 1999-05-20 2003-11-11 Chitogenics, Inc. Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
HUP0202846A3 (en) * 1999-09-24 2003-12-29 Smithkline Beecham Biolog Intranasal influenza virus vaccine
CA2433967A1 (en) * 2001-01-05 2002-07-11 Intercell Ag Anti-inflammatory use of polycationic compounds
WO2003002069A2 (en) * 2001-06-29 2003-01-09 Becton, Dickinson And Company Intradermal delivery of vaccines and gene therapeutic agents via microcannula
CA2481227C (en) * 2002-03-28 2012-07-31 Chitogenics, Inc. Adherent n,o-carboxymethylchitosan drug delivery devices for moist tissue and methods of their use
WO2004075829A2 (en) * 2003-01-30 2004-09-10 Chiron Corporation Adjuvanted influenza vaccine
US7588774B2 (en) * 2003-05-12 2009-09-15 Becton, Dickinson And Company Molecules enhancing dermal delivery of influenza vaccines
US20050123550A1 (en) * 2003-05-12 2005-06-09 Laurent Philippe E. Molecules enhancing dermal delivery of influenza vaccines
CA2548210A1 (en) * 2003-12-05 2005-08-18 Becton, Dickinson And Company Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods
US7319032B2 (en) * 2004-04-22 2008-01-15 Medtox Non-sugar sweeteners for use in test devices
WO2006039659A1 (en) * 2004-10-02 2006-04-13 Sri International Bioadhesive delivery system for transmucosal delivery of beneficial agents
US20060121055A1 (en) * 2004-12-06 2006-06-08 Becton, Dickinson And Company, Inc. Compositions with enhanced immunogenicity
US9650639B2 (en) 2008-05-19 2017-05-16 Advaxis, Inc. Dual delivery system for heterologous antigens
EP3275507B1 (de) * 2011-04-18 2020-02-26 University Of Georgia Research Foundation, Inc. Impfstoffabgabeverfahren
WO2015082965A2 (en) * 2013-12-04 2015-06-11 Melder C Patrick Novel chitosan nasal wash

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261264A (en) 1984-11-29 1989-09-26 Shigeo Suzuki Immunopotentiating agents and method
ATE194651T1 (de) 1989-10-16 2000-07-15 Amgen Inc Stammzellenfaktor
US5593683A (en) * 1990-05-01 1997-01-14 Mdv Technologies, Inc. Method of making thermoreversible polyoxyalkylene gels
US5300295A (en) * 1990-05-01 1994-04-05 Mediventures, Inc. Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
US5071644A (en) * 1990-08-07 1991-12-10 Mediventures, Inc. Topical drug delivery with thermo-irreversible gels
US5622649A (en) * 1991-06-27 1997-04-22 Emory University Multiple emulsions and methods of preparation
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
EP1181937A3 (de) 1994-08-09 2004-02-04 Cytrx Corporation Nukleinsäure enthaltender Impfstoff, Impfstoff-adjuvans
US5912000A (en) 1994-09-23 1999-06-15 Zonagen, Inc. Chitosan induced immunopotentiation
US5939485A (en) 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
EP0832151A2 (de) * 1995-06-16 1998-04-01 Gel Sciences, Inc. Auf umweltänderungen reagierende polymernetzwerke und verfahren zu deren herstellung
US5702717A (en) 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
GB9525083D0 (en) 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
US5902110A (en) 1995-12-18 1999-05-11 The Block Drug Company Bone regeneration
US5861174A (en) 1996-07-12 1999-01-19 University Technology Corporation Temperature sensitive gel for sustained delivery of protein drugs
ES2114502B1 (es) * 1996-07-29 1999-07-01 Univ Santiago Compostela Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.
EP0920338A2 (de) * 1996-08-12 1999-06-09 MedLogic Global Corporation Zusammensetzung für pharmazeutischen anwendungen
AU5906898A (en) 1997-01-02 1998-07-31 Medlogic Global Corporation Responsive polymer networks and methods of their use
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
US6201072B1 (en) 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6004573A (en) 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6117949A (en) 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
EP1041996A4 (de) 1997-12-22 2003-05-14 Human Genome Sciences Inc Keratinozyten wachstumsfaktor-2 formulierungen
US6280742B1 (en) 1998-06-17 2001-08-28 Zonagen, Inc. Methods and materials for the treatment of prostatic carcinoma
WO2000007603A2 (en) 1998-08-04 2000-02-17 Madash Llp End modified thermal responsive hydrogels
WO2000056361A2 (en) 1999-03-24 2000-09-28 The Secretary Of State For Defence Vaccine composition
WO2001012218A1 (en) 1999-08-16 2001-02-22 Zonagen, Inc. Methods and materials for the treatment of prostatic carcinoma
OA12028A (en) 1999-09-25 2006-04-28 Univ Iowa Res Found Immunostimulatory nucleic acids.
US20010044416A1 (en) 2000-01-20 2001-11-22 Mccluskie Michael J. Immunostimulatory nucleic acids for inducing a Th2 immune response
WO2002000171A2 (en) * 2000-06-26 2002-01-03 Rxkinetix, Inc. Composition for delivery of hematopoietic growth factor

Also Published As

Publication number Publication date
EP1315672A4 (de) 2006-04-26
WO2001098206A1 (en) 2001-12-27
US7767197B2 (en) 2010-08-03
EP1315672A1 (de) 2003-06-04
US20020025326A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2001263996A1 (en) Prolonged release microspheres for injection delivery and preparation method
AU2001285143A1 (en) Methods and compositions for targeted delivery
AU2002245165A1 (en) Method and device for ultrasound drug delivery
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU2001233543A1 (en) Carrier particles for drug delivery and process for preparation
AU2001276831A1 (en) Delivery vehicle composition and methods for delivering antigens and other drugs
AU6271401A (en) Drug administering system and administering method
AU2002326494A1 (en) Products and drug delivery vehicles
AU2001270300A1 (en) Drug delivery formulations and targeting
AUPQ867700A0 (en) Delivering multimedia descriptions
AU2002241538A1 (en) Intrasvascular drug delivery device and use therefor
AU4477001A (en) Injectable sustained release pharmaceutical composition and processes for preparing the same
AU1719800A (en) Drug delivery systems and methods
AU4985600A (en) Drug delivery device
IL138990A0 (en) Matrices for drug delivery and methods for making and using the same
AU2001288388A1 (en) Substance delivery system
AU2001235009A1 (en) Drug delivery apparatus
IL162183A0 (en) Polymer-lipid delivery vehicles and methods for the preparation thereof
AU2001268459A1 (en) Secure test and test result delivery system
AU4947100A (en) Drug delivery device
AU2002225878A1 (en) Receptor antagonist-lipid conjugates and delivery vehicles containing same
AU2002236647A1 (en) Method and device for administering medication and/or placebo
AU4668601A (en) Microprojectile delivery system and particulate product
AU2001244713A1 (en) Transporters and drug delivery system by using the same
AU2001232020A1 (en) Floating drug delivery composition